ARTERIAL HYPERTENSION AND POTENTIALS FOR USE OF Β-BLOCKERS


Cite item

Full Text

Abstract

This article discusses the use of β-blockers in the treatment of arterial hypertension (AH). The results of study aimed to evaluation of efficacy of cardioselective beta-blocker Bisogamma (Bisoprolol) in the treatment of 48 hypertensive patients show metabolic neutrality of this drug, ability to improve the blood rheological properties and prevent the progression of changes in the arterial vessels in such patients.

References

  1. Rose G. Sick individuals and sick populations. Int J Epidemiol 2001;30:427-32.
  2. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension 2003;42:1206-52.
  3. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-92.
  4. Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25(6):1105-87.
  5. Диагностика и лечение артериальной гипертензии, Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского научного общества кардиологов, приложение 2 к журналу "Кардиоваскулярная терапия и профилактика". 2008. № 7(6).
  6. Карпов Ю.А. Европейские рекомендации по артериальной гипертонии - главное событие 2007 года // РМЖ. 2007. № 20. C. 1405-8.
  7. Williams B, Poulter NR, Brown MJ, et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004;328:634-64.
  8. Okin PM, Devereux RB, Jern S, et al. LIFE Study Investigators Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA. 2004;292(19):2343-49.
  9. Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as rquired, in the Anglo-Scandinavian Cardiac Outcomes Trial - Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005;366:895-906.
  10. Williams B, Lacy PS, Thom SM, et al.CAFE Investigators; Anglo- Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113:1213-25.
  11. Morgan T. Effect of different antihypertensive drug classes on central aortic pressure. / T. Morgan, J. Lauri, D. Bertram, A. Anderson. Am J Hypertens 2004;17:118-23.
  12. Hirata K, Vlachopoulos C, Adji A, et al. Benefits from angiotensin- converting enzyme inhibitor "beyond blood pressure lowering" beyond blood pressure or beyond the brachial artery? J Hypertens 2005;23:551-56.
  13. London GM, Asmar RG, O'Rourke MF, et al. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol 2004;43:92-9.
  14. Haasis R, Bethge H. Exercise blood pressure and heart rate reduction 24 and 3 hours after drug intake in hypertensive patients following 4 weeks of trearment with bisoprolol and metoprolol: a randomized multicentre double-blind study (BISOMET). Eur Heart J 1987;8:103-13.
  15. Gosse P, Roudaut R, Herrero G, et al. Beta-blockers vs angiotensin-converting enzyme inhibitors in hypertension: effects of left ventricular hypertrophy. J Cardiovasc Pharmacol 1990;16(5):145-50.
  16. Prisant LM, Weir MR, Frishman WH, et al. Self Reported Sexual Dysfunction in Men and Women Treated With Bisoprolol, Hydrochlorothiazide, Enalapril, Amlodipine, Placebo, or Bisoprolol/Hydrochlorothiazide. J Clin Hypertens (Greenwich). 1999;1(1):22-6.
  17. Fogari R, Zoppi A, Tettamanti F, et al. B-blocer effects on plasma lipids in antihypertensive therapy. J Cardiovasc Pharmacol 1990;16(5):76-80.
  18. Koning L, Merchant AT, Pogue J, et al. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. European Heart Jornal 2007;28(7):850-56.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies